On the other hand, in rat models of high-fat diet-induced obesity that have functioning leptin receptors, such as Sprague-Dawley rats [32] and Wistar Kyoto rats [27], treatment with palmitoylated PrRP significantly decreased BW and blood glucose, as indicated by OGTTs. Here, PRLH is linked to obesity due to melanocortin 4 receptor deficiency.